When was RxFunction founded?

RxFunction was founded in 2010 and raised its 1st funding round 1 year after it was founded.

Where is RxFunction located?

RxFunction is headquartered in Minneapolis, United States. It is registered at Eden Prairie, Minnesota.

Who is the current CEO of RxFunction?

Mary Ernst Anderson of RxFunction.

How many employees does RxFunction have?

As of Sep 30, 2026, the latest employee count at RxFunction is 88.

Is RxFunction a funded company?

RxFunction is a funded company, having raised a total of $39.9M across 13 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Sep 14, 2011.

When was the latest funding round of RxFunction?

RxFunction's latest funding was a $***** Series B round on Oct 27, 2022, with participation from 0 investor.

Where does RxFunction rank among its competitors?

RxFunction ranks 15th amongst 106 active competitors, of which 38 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Wearable Robotics, which secured an undisclosed amount in Apr, 2026.

Who are the top competitors of RxFunction?

RxFunction's top competitors include HyperIce, AxoGen and Fundamental Surgery. Among them, Wearable Robotics secured the most recent funding round in April, 2026.

RxFunction - 2026 Company Profile, Team, Funding & Competitors

Company Details

RxFunction provides wearable prostheses for people with sensory peripheral neuropathy. It develops advanced balance technology solutions, aiming to aid patients with loss of balance. The product consists of a leg unit and a footpad (insoles). The product's insoles measure the patient's foot pressure and provide real-time tactile sensory cues to help control balance and stability. The leg unit wraps around the lower leg of the user and contains electronics for reading the insole signals, a microprocessor as well as four vibrating motors that provide tactile sensory cues to the user.

Website: rxfunction.com
Social
Email ID: *****@rxfunction.com
Registered Address: Eden Prairie, Minnesota

Key Metrics

Founded Year

2010

Location

Minneapolis, United States

Stage

Series B

Total Funding

$39.9M in 13 rounds

Latest Funding Round

Series B, Oct 27, 2022, $*****

Investors

HHS & 1 more

Ranked

15^th among 106 active competitors

Employee Count

88 as on Sep 30, 2026

Similar Companies

AxoGen & 106 more

View RxFunction's full profile

RxFunction is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
RXFUNCTION, INC. CIN: 273029348 , United States, Active	May 16, 2010	-	65 (As on Dec 31, 2024)	-

RxFunction has raised a total funding of $39.9M over 13 rounds. Its first funding round was on Sep 14, 2011. RxFunction has 2 institutional investors.

Here is the list of recent funding rounds of RxFunction:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 27, 2022	5646075	Series B	3907384	8288787	3884820	5115664
Jan 14, 2021	6943635	Series A	7385184	1375015	7567714	2037232
Dec 09, 2020	4589106	Series A	7057755	3541249	6834289	3641352

Access funding benchmarks and valuations. Sign up today!

View details of RxFunction's funding rounds and investors

Here are the details of RxFunction's key team members:

Mary Ernst Anderson: CEO of RxFunction.
Contact Info: 1 email address

RxFunction's Board of Directors

RxFunction's board has 15 active members. Robert Rinek, Mary Anderson, Kevin Roche, Richard Offerdahl, Kevin H. Roche, Joseph Daniel Leach, Thomas E. Morizio, Thomas Morizio, Richard J. Nigon, Mary E. Anderson, Robert P. Rinek, Richard Nigon, Joseph D. Leach, Joseph Schauer and Lars Oddsson are independent board members.

Here is the list of RxFunction's board of directors:

Name	Type	Representing	Status	Duration
Robert Rinek	Independent board member	-	Current	8y 8m
qmlzpoz	Independent board member	-	Current	4y 2m
wgmsrnm	Independent board member	-	Current	8y 4m
suxsrml	Independent board member	-	Current	9y 7m
tdpkqes	Independent board member	-	Current	1y 8m
sortaiv	Independent board member	-	Current	9y 1m
vutbhpw	Independent board member	-	Current	9y 8m
kcggwsh	Independent board member	-	Current	3y 5m
alapeit	Independent board member	-	Current	9y 2m
yq{zunx	Independent board member	-	Current	4y 9m
pxzcwfn	Independent board member	-	Current	2y 8m
gdncpgm	Independent board member	-	Current	5y 2m
rquu{rv	Independent board member	-	Current	8y 8m
vlyfgrm	Independent board member	-	Current	8y 6m
jlqfojd	Independent board member	-	Current	1y 1m

View details of RxFunction's Founder profiles and Board Members

RxFunction's employee count trend

RxFunction has 88 employees as of Sep 26. Here is RxFunction's employee count trend over the years:

Uncover RxFunction's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of RxFunction include HyperIce, AxoGen and Fundamental Surgery. Here is the list of Top 10 competitors of RxFunction, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	HyperIce 2011, Irvine (United States), Series C	Internet first brand offering smart devices for physical fitness	$52.5M	MainStreet Advisors, SC.Holdings & 38 others	69/100
2nd	AxoGen 2002, Alachua (United States), Public	Developer of therapies for the repair of peripheral nerve injuries	$62.4M	Oberland Capital, Cardinal Partners & 10 others	65/100
3rd	Fundamental Surgery 2012, Boston (United States), Series B	Provider of AI-based platform for surgical simulation using VR and haptics	$39.6M	EQT, Downing & 13 others	63/100
4th	Neocis 2012, Miami (United States), Series D	Provider of robotic guidance system for dental surgeries	$179M	DFJ Growth, Norwest & 12 others	63/100
5th	BioCircuit 2016, Atlanta (United States), Acquired	Developer of non-invasive electrophysiology devices to monitor peripheral nerves	$13.6M	Masters Capital Management, GRA Venture Fund ... & 4 others	57/100
6th	Tulavi Nerve Therapeutics 2020, Mountain View (United States), Series A	Developer of the therapeutic device to treat neurally mediated diseases	$11.5M	Ascension Ventures, AMED Ventures & 1 others	56/100
7th	KT Tape 2009, American Fork (United States), Acquired	Manufacturer of kinesiology tape, health products, and related application accessories	-	Palladin Consumer Retail Partners	56/100
8th	Wearable Robotics 2014, Pisa (Italy), Series A	Exoskeletons and robotic rehabilitation devices	$8.51M	Progress Tech Transfer, CDP Venture Capital ... & 8 others	53/100
9th	Startoon Labs 2017, Secunderabad (India), Seed	Developer of medical device for physiotherapy assessment, monitoring, and reporting	$465K	IKP Knowledge Park, Guptaji invests & 14 others	52/100
10th	Flint Rehab 2011, Irvine (United States), Early Stage	Developer of stroke rehabilitation systems	$8M	NICHD, HHS & 1 others	52/100
15th	RxFunction 2010, Minneapolis (United States), Series B	Provider of wearable prosthesis for people with sensory peripheral neuropathy	$39.9M	HHS & 1 others	43/100